Učitavanje...
Advances and challenges: dendritic cell vaccination strategies for glioblastoma
INTRODUCTION: Glioblastoma is the most common primary brain tumor in adults and prognosis remains poor with a median survival of approximately 15–17 months. This review provides an overview of recent advances in the field of glioblastoma immunotherapy. AREAS COVERED: Recent advances in dendritic cel...
Spremljeno u:
| Izdano u: | Expert Rev Vaccines |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479410/ https://ncbi.nlm.nih.gov/pubmed/27500911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2016.1218762 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|